sec filing
AC
NASDAQ · ACXP
Acurx Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.04
Up+$0.01 (+0.97%)
Updated Nov 21, 2026, 12:41 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.38M
- P/E ratio
- -0.27
- Dividend yield
- 0.00%
- 52-week range
- $0.90 – $7.54
- Volume
- 154.33K
- Avg. volume
- 61.79K
Price performance · ACXP
ACXP price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 20, 2026
ACXP closed at $1.04 after 21 trading sessions, down 8.37% for the selected period.
- Last close
- $1.04
- Period change
- -8.37%
- Period low
- $0.94
- Period high
- $1.14
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | $1.11 | $1.12 | $1.02 | $1.04 | 154.33K |
| Nov 19, 2026 | $1.025 | $1.105 | $1.025 | $1.03 | 131.97K |
| Nov 18, 2026 | $1.03 | $1.03 | $0.96 | $1.00 | 78.5K |
| Nov 17, 2026 | $1.00 | $1.03 | $0.954 | $0.99 | 232.46K |
| Nov 16, 2026 | $1.00 | $1.04 | $0.90 | $0.935 | 119.49K |
| Nov 13, 2026 | $1.04 | $1.04 | $0.92 | $0.96 | 223.47K |
| Nov 12, 2026 | $1.05 | $1.0601 | $0.98 | $0.985 | 159.19K |
| Nov 11, 2026 | $1.05 | $1.08 | $1.03 | $1.03 | 99.82K |
| Nov 10, 2026 | $1.06 | $1.09 | $1.02 | $1.04 | 66.35K |
| Nov 9, 2026 | $1.06 | $1.1229 | $1.06 | $1.06 | 118.79K |
| Nov 6, 2026 | $1.01 | $1.08 | $1.01 | $1.06 | 122.67K |
| Nov 5, 2026 | $1.11 | $1.11 | $0.9457 | $0.9457 | 189.99K |
| Nov 4, 2026 | $1.07 | $1.0761 | $1.0159 | $1.03 | 171.47K |
| Nov 3, 2026 | $1.07 | $1.111 | $1.01 | $1.02 | 206.92K |
| Nov 2, 2026 | $1.08 | $1.12 | $1.0451 | $1.07 | 143.69K |
| Oct 30, 2026 | $1.09 | $1.1026 | $1.035 | $1.04 | 63.19K |
| Oct 29, 2026 | $1.06 | $1.11 | $1.06 | $1.07 | 64.57K |
| Oct 28, 2026 | $1.08 | $1.0801 | $1.05 | $1.07 | 61.18K |
| Oct 27, 2026 | $1.08 | $1.0961 | $1.05 | $1.06 | 58.37K |
| Oct 26, 2026 | $1.12 | $1.135 | $1.0809 | $1.085 | 64.39K |
| Oct 23, 2026 | $1.135 | $1.14 | $1.12 | $1.135 | 22.15K |
Latest ACXP news
The latest Smart Investors Daily articles mentioning ACXP.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

